##gff-version 3
##sequence-region Q96A57 1 120
Q96A57	UniProtKB	Chain	1	120	.	.	.	ID=PRO_0000233892;Note=Transmembrane protein 230	
Q96A57	UniProtKB	Transmembrane	46	66	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q96A57	UniProtKB	Transmembrane	79	99	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q96A57	UniProtKB	Modified residue	15	15	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q96A57	UniProtKB	Modified residue	23	23	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19690332;Dbxref=PMID:19690332	
Q96A57	UniProtKB	Modified residue	24	24	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q96A57	UniProtKB	Alternative sequence	1	1	.	.	.	ID=VSP_018155;Note=In isoform 1. M->MQPWALPTVGELWVCGRPGAALRWSLVLSPRLEPSGVISAHCNLHLLASSDSSASASRLCQRVM;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.1	
Q96A57	UniProtKB	Natural variant	29	29	.	.	.	ID=VAR_076713;Note=In PARK%3B sporadic case%3B unknown pathological significance%3B results in decreased synaptic vesicle trafficking. Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27270108;Dbxref=dbSNP:rs1056737920,PMID:27270108	
Q96A57	UniProtKB	Natural variant	78	78	.	.	.	ID=VAR_076714;Note=In PARK%3B unknown pathological significance%3B results in decreased synaptic vesicle trafficking. R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27270108;Dbxref=dbSNP:rs764786986,PMID:27270108	
Q96A57	UniProtKB	Natural variant	108	108	.	.	.	ID=VAR_076715;Note=R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27270108;Dbxref=dbSNP:rs143571424,PMID:27270108	
Q96A57	UniProtKB	Sequence conflict	59	61	.	.	.	Note=LII->SY;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q96A57	UniProtKB	Sequence conflict	109	109	.	.	.	Note=G->A;Ontology_term=ECO:0000305;evidence=ECO:0000305	
